Otoscreen
Status:
SDGs:
Industry:
Impact:
Origin:
School:
Established:
The WHO estimates that 1/4 of the global population will have hearing loss by 2050 and that even 80% will go undiagnosed. Otoscreen’s solution enables doctors to diagnose multiple hearing loss patients in just minutes. This will reform healthcare and save its resources.
Addressing hearing loss is crucial due to the expected rise in hearing loss cases, which could lead to a significant economic burden by 2050. Early identification of hearing loss is crucial for effective treatment, reducing costs and functional decline associated with the condition. This project explores solutions that result in earlier intervention. Benefits include efficiency, actionability, and reach, leading to improvements in quality of life, productivity and social inclusion.
Contact
Tanja Tervonen
News from innovation ecosystem
Influenza vaccinations in occupational health care in autumn 2026
Also this fall, Aalto's employees will be offered free basic level influenza vaccinations.
Send your nominations for ELEC Awards 2026
We are celebrating those awarded in 2026 for teaching, research, impact, and other work done for our community. Send in your nominations on the 21st of November the latest!
Student exchange in Europe? Unite! can take you there
Aalto is a member of Unite!, a European university alliance that gives students the opportunity to internationalise their degrees both online and in-person. Join the webinar to find out more.